Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine

Por Saubi, N, Gea-Mallorquí, E, Mbewe-Mvula, A, Hurtado, C, Gatell, J, Hanke, T, Joseph, J
Publicado em 2012

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Por Saubi, N, Im, E, Fernandez-Lloris, R, Gil, O, Cardona, P, Gatell, J, Hanke, T, Joseph, J
Publicado em 2009

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.

Por Gatell, J M, Ferran, F, Araujo, V, Bonet, M, Soriano, E, Traserra, J, SanMiguel, J G
Publicado em 1987

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate

Por Rodriguez-Garcia, M, Climent, N, Oliva, H, Rovira, C, Miralles, L, Leon, A, Gatell, J, Garcia, F, Gallart, T
Publicado em 2009

Cellular immune responses and changes in VL after a Dendritic Cells (DC)-based therapeutic vaccine in cART treated chronic HIV-infected patients with CD4 T cells above 450/mm

Por García, F, Guardo, AC, Maleno, M, Papagno, L, Bargalló, M, Climent, N, Autran, B, Gatell, J, Gallart, T, Plana, M
Publicado em 2012

Fatal and non-fatal AIDS and non-AIDS events in HIV-1 infected patients with high CD4 counts

Por Reekie, J, Gatell, J, Yust, I, Bakowska, E, Rachmanova, A, Losso, M, Krasnov, M, Francioli, P, Kowalska, J, Mocroft, A
Publicado em 2010

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Por Viard, JP, Souberbielle, JC, Kirk, O, Knysz, B, Losso, M, Gatell, J, Pedersen, C, Bogner, JR, Mocroft, A, Lundgren, JD
Publicado em 2010

Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.

Por Lundgren, J. D., Pedersen, C., Clumeck, N., Gatell, J. M., Johnson, A. M., Ledergerber, B., Vella, S., Phillips, A., Nielsen, J. O.
Publicado em 1994

Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients

Por Egaña-Gorroño, L., Martínez, E., Domingo, P., Loncà, M., Escribà, T., Fontdevila, J., Vidal, F., Negredo, E., Gatell, J. M., Arnedo, M.
Publicado no Antimicrob Agents Chemother (2014)

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse

Por Pacheco, R., Martinez-Navio, J. M., Lejeune, M., Climent, N., Oliva, H., Gatell, J. M., Gallart, T., Mallol, J., Lluis, C., Franco, R.
Publicado em 2005

Regional differences in presentation of AIDS in Europe.

Por Blaxhult, A., Kirk, O., Pedersen, C., Dietrich, M., Barton, S. E., Gatell, J. M., Mulcahy, F., Hirschel, B., Mocroft, A., Lundgren, J. D.
Publicado em 2000

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection

Por Mocroft, A, Ryom, L, Reiss, P, Furrer, H, D’Arminio Monforte, A, Gatell, J, de Wit, S, Beniowski, M, Lundgren, JD, Kirk, O
Publicado no HIV Med (2014)

Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.

Por Gatell, J M, SanMiguel, J G, Araujo, V, Zamora, L, Maña, J, Ferrer, M, Bonet, M, Bohe, M, Jimenez de Anta, M T
Publicado em 1984

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1

Por Guilà, M, Dalmau, J, Gil, C, Martinez-Picado, J, García, F, Climent, N, García, M, Hurtado, C, Pumarola, T, Miró, J, Gallart, T, Gatell, J
Publicado em 2009

Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.

Por Fernandez, P., Torres, A., Miro, J. M., Vieigas, C., Mallolas, J., Zamora, L., Gatell, J. M., Valls, M. E., Riquelme, R., Rodríguez-Roisin, R.
Publicado em 1995

Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.

Por Gatell, J M, San Miguel, J G, Zamora, L, Araujo, V, Bonet, M, Bohé, M, Jimenez de Anta, M T, Farré, M, Elena, M, Ballesta, A, Marin, J L
Publicado em 1983

A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study

Por Sönnerborg, A, Mocroft, A, Lundgren, JD, Raben, D, Gatell, J, Vassilenko, A, Hadziosmanovic, V, Bergovac, J, Sørensen, H, Cusini, M, Clumeck, N, Gazzard, B, Rockstroh, J, Zuin, M, D'Arminio Monforte, A
Publicado em 2010

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

Por Miró, J. M., García-de-la-Mària, C., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Sarasa, M., Mestres, C. A., Gatell, J. M., Jiménez de Anta, M. T., Marco, F.
Publicado em 2009

Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable Viremia

Por Medina-Ramírez, M., Sánchez-Merino, V., Sánchez-Palomino, S., Merino-Mansilla, A., Ferreira, C. B., Pérez, I., González, N., Alvarez, A., Alcocer-González, J. M., García, F., Gatell, J. M., Alcamí, J., Yuste, E.
Publicado em 2011

Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection

Por Sanchez-Merino, V., Fabra-Garcia, A., Gonzalez, N., Nicolas, D., Merino-Mansilla, A., Manzardo, C., Ambrosioni, J., Schultz, A., Meyerhans, A., Mascola, J. R., Gatell, J. M., Alcami, J., Miro, J. M., Yuste, E.
Publicado no J Virol (2016)